Evidence map›Paper›PMID 33849659›Full record

ArticleStem cell research & therapy2021

Identification of circulating CD31

Maria Chiara G Monaco, Dragan Maric, Ombretta Salvucci, Cristina Antonetti Lamorgese Passeri, Patrizia Accorsi, Eugene O Major, Anna Concetta Berardi

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Stem cell research & therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Maria Chiara G Monaco *Viral Immunology Section, National Institute of Neurological, Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Dragan Maric *NINDS Flow Cytometry Core Facility, National Institutes of Health, Bethesda, MD, USA.
Ombretta Salvucci *Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Cristina Antonetti Lamorgese PasseriDepartment of Haematology, Laboratory of Stem Cells, Transfusion Medicine and Biotechnologies, Santo Spirito Hospital, Pescara, Italy.
Patrizia AccorsiDepartment of Haematology, Transfusion Medicine and Biotechnologies, Santo Spirito Hospital, 65125, Pescara, Italy.
Eugene O MajorLaboratory of Molecular Medicine and Neuroscience, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Anna Concetta BerardiDepartment of Haematology, Laboratory of Stem Cells, Transfusion Medicine and Biotechnologies, Santo Spirito Hospital, Pescara, Italy. annacberardi@yahoo.it.ORCID 0000-0002-5078-6158
National Institutes of Health · USOspedale di Santo Spirito · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erythro-myeloid progenitors (EMP) are found in a population of cells expressing CD31 and CD45 markers (CD31

Indexed as

Endothelial CellsHematopoietic SystemAdultCell DifferentiationErythroid CellsHematopoiesisHumansCD31+CD45+ circulating cellsErythro-myeloid progenitorsHuman erythropoiesis

Identifiers

PMID33849659
PMCPMC8042691
OpenAlexW3156156753

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.